The Global Head and Neck Squamous Cell Carcinoma (HNSCC) Market is projected to grow at around 9.5% CAGR during the forecast period, i.e., 2022-27. The growth of the market is driven primarily by the mounting prevalence of HNSCC, i.e., augmenting the demand for diagnosis & treatment and, in turn, instigating governments of different countries to increase their respective healthcare expenditures for drug developments to cater to the high unmet requirements of patients worldwide.